Мобильная версия

Доступно журналов:

3 288

Доступно статей:

3 891 637

 

Скрыть метаданые

Дата выпуска 1988
dc.description DMDM Hydantoin is a preservative, which is used in cosmetic products at concentrations up to 1%. This ingredient is a formaldehyde donor containing up to 2% of the free aldehyde in equilibrium with the hydantoin. When <sup>14</sup>C-DMDM Hydantoin was applied to the middorsal area of Sprague-Dawley rats, more than 98% of the recovered radioactivity was confined to the dose site. The LD<sub>50</sub> dermal and oral toxicity of DMDM Hydantoin was greater than 2 g/kg. No significant toxic effects were noted in a subchronic oral toxicity study. In skin irritation studies using product formulations, results ranged from non-irritating to moderate skin irritation. At most, transient minimal irritation was noted in albino rabbits treated with DMDM Hydantoin formulations. The mutagenicity of DMDM Hydantoin formulations varies in accordance with the test system. The ingredient was not mutagenic in one Salmonella/microsome assays but was in another. Both positive and negative mutagenic activities were reported when DMDM Hydantoin was tested in the L5178y TK± mouse lymphoma assay. The ingredient was mutagenic in the chromosome aberrations and unscheduled DNA synthesis assays but was not mutagenic in unscheduled DNA synthesis and DNA strand breaks/crosslinks assays. A comparison of Ames test results from studies of DMDM Hydantoin product and formaldehyde indicates a similar number of reversants per formaldehyde equivalent. In clinical studies, skin irritation ranged from none to observations of intense erythema and edema when various formulations containing DMDM Hydantoin were applied. DMDM Hydantoin formulations did not induce sensitization in some clinical studies. DMDM Hydantoin formulations were neither phototoxic nor photoallergenic. Use of DMDM Hydantoin at its current concentration of use in cosmetic products would not expose the consumer to levels of formaldehyde above the limit previously considered as acceptable in cosmetic products. Based on the available data included in this report, it is concluded that DMDM Hydantoin is safe as a cosmetic ingredient in the present practices of use.
Издатель SAGE Publications
Название 1 Final Report on the Safety Assessment of DMDM Hydantoin
Тип Journal Article
DOI 10.3109/10915818809023133
Electronic ISSN 1092-874X
Print ISSN 1091-5818
Журнал International Journal of Toxicology
Том 7
Первая страница 245
Последняя страница 277
Выпуск 3
Библиографическая ссылка 1. Estrin, N.F., Crosley, P.A., and Haynes, C.R. (1982). CTFA Cosmetic Ingredient Dictionary. Washington, DC: Cosmetic, Toiletry and Fragrance Association, Inc., pp. 94–95.
Библиографическая ссылка 2. Rosen, M. (1984). Glydant and MDMH as cosmetic preservatives. In Cosmetic and Drug Preservation, Principles and Practice. New York: Marcel Dekker, pp. 166–70, 173.
Библиографическая ссылка 3. Hunting, A.L.L. (1983). Encyclopedia of Shampoo Ingredients. Cranford, NJ: Micelle Press, p. 211.
Библиографическая ссылка 4. Shimodoi, Y. (1966). Dimethylolhydantoin. Japanese Patent 4709.
Библиографическая ссылка 5. Foelsch, D.H. (1976). Dimethyloldimethylhydantoin solution. U.S. Patent 3,987,184.
Библиографическая ссылка 6. Cosmetic, Toiletry And Fragrance Association (CTFA). (no date). Photospectrum analysis of a 55.0% DMDM Hydantoin formulation. CTFA Code No. 3-5-31.*
Библиографическая ссылка 7. Schanno, R.J., Westlund, J.R., and Foelsch, D.H. (1980). Evaluation of 1,3-dimethylol-5,5-dimethyl hydantoin as a cosmetic preservative. J. Soc. Cosmet. Chem. 31, 85–96.
Библиографическая ссылка 8. Code Of Federal Regulations (CFR). (Revised April 1, 1984). Title 21 Part 720.4. Voluntary filing of cosmetic product ingredient and cosmetic raw material composition statement. Information requested about cosmetic products.
Библиографическая ссылка 9. U.S. Food And Drug Administration. (1981). Cosmetic product formulation data. FDA computer printout.
Библиографическая ссылка 10. Chiu, S.K., Keifer, L., and Timberlake, J.W. (1979). Synthesis of imidazolidinediones and oxazolidinediones from cyclization of propargylureas and propargyl carbamates. J. Med. Chem. 22(6), 746–48.
Библиографическая ссылка 11. EG And G Mason Research Institute. (1983). Distribution study of 5,5′-Dimethylhydantoin-5-14C (C5H8N2O2) on male Sprague-Dawley rats. Report no. MRI-206-GC-83–35. Submitted to Control Data Healthcare Services, Rockville, MD, for Glyco Chemicals, Inc.*
Библиографическая ссылка 12. Warf Institute, Inc. (1976). Acute inhalation study of a DMDM Hydantoin product formulation. Study no. 6051229.*
Библиографическая ссылка 13. Food And Drug Research Laboratories, Inc. (FDRL). (1981). Acute inhalation toxicity of a DMDM Hydantoin formulation in Sprague-Dawley rats. Study no. 6872. Submitted to Glyco Chemicals, Inc.*
Библиографическая ссылка 14. Industrial Bio-Test Laboratories, Inc. (1976). Acute oral toxicity study with a DMDM Hydantoin formulation in albino rats. Study no. 8530–09420.*
Библиографическая ссылка 15. Industrial Bio-Test Laboratories, Inc. (1976). Human repeated insult patch test with a DMDM Hydantoin formulation. Study no. 8537–09670. Submitted to Glyco Chemicals, Inc.*
Библиографическая ссылка 16. Stillmeadow, Inc. (1980). Acute oral toxicity study of a mascara product containing 0.4% DMDM Hydantoin. CTFA Code No. 3-5-30.*
Библиографическая ссылка 17. CTFA. (1981). Safety Data Test Summary Response form. Acute oral toxicity. CTFA Code no. 3-4-3.*
Библиографическая ссылка 18. FDRL. (1982). Ninety-day oral toxicity of a DMDM Hydantoin formulation in Sprague-Dawley rats. Study no. 7059. Submitted to Glyco Chemicals, Inc.*
Библиографическая ссылка 19. WARF Institute, Inc. (1976). Acute oral toxicity of a DMDM Hydantoin formulation. Study No. 6051229.*
Библиографическая ссылка 20. CFR. (Revised April 1, 1984). Title 16 Part 1500.3 Section (b)(6)(i)(A). Protocol for acute oral toxicity study. Washington, DC: U.S. Government Printing Office.
Библиографическая ссылка 21. CRF. (Revised April 1, 1984). Title 16 Part 1500.3 Section (c)(1)(ii)(c) and Part 1500.40. Procedures for acute dermal toxicity study. Washington, DC: U.S. Government Printing Office.
Библиографическая ссылка 22. CTFA. (1981). Safety Data Test Summary Response form. Acute oral toxicity. CTFA Code no. 3-4-3.*
Библиографическая ссылка 23. BIO-TEST Laboratories, Inc. (1977). Twenty-eight day subacute dermal toxicity study of a DMDM Hydantoin formulation in albino rabbits. Study no. 8530-09671. Submitted to Glyco Chemicals, Inc.*
Библиографическая ссылка 24. International Research And Development Corporation. (1982). Percutaneous rabbit teratology study. Study no. 191–756.*
Библиографическая ссылка 25. Bio/Dynamics, Inc. (1983). Twenty-eight/ninety-one day subchronic percutaneous toxicity study in rabbits with a DMDM Hydantoin formulation. Study no. 82-2622.*
Библиографическая ссылка 26. CTFA. (1981). Safety Data Test Summary Response form. Skin irritation. CTFA Code no. 3-4-3.*
Библиографическая ссылка 27. Stillmeadow, Inc. (1980). Skin irritation study of a mascara product containing 0.4% DMDM Hydantoin. CTFA Code No. 3-5-27.*
Библиографическая ссылка 28. CTFA. (1981). Safety Data Test Summary Response form. Mucous membrane irritation. CTFA Code no. 3-4-4.*
Библиографическая ссылка 29. CFR. (Revised April 1, 1984). Title 16 Part 1500.3 Section (c)(4) and Part 1500.41. Primary skin irritation study protocol. Washington, DC: U.S. Government Printing Office.
Библиографическая ссылка 30. CFR. (Revised April 1, 1984). Title 16 part 1500.3 (c)(4) and 1500.42. Ocular irritation study protocol. Washington, DC: U.S. Government Printing Office.
Библиографическая ссылка 31. CTFA. (1981). Safety Data Test Summary Response form. Ocular irritation. CTFA Code no. 3-4-3.*
Библиографическая ссылка 32. Draize, J.H., Woodward, G., and Calvery, H.O. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther. 82, 377–90.
Библиографическая ссылка 33. Bio/Dynamics, Inc. (1978). Rabbit eye irritation study. Study no. 4613–77. Submitted to Glyco Chemicals, Inc.*
Библиографическая ссылка 34. CTFA. (1982). Industry submission from Stillmeadow, Inc. Rabbit eye irritation. CTFA Code no. 3-4-13.*
Библиографическая ссылка 35. Stillmeadow, Inc. (1980). Ocular irritation study of a mascara product containing 0.4% DMDM Hydantoin. CTFA Code No. 3-5-28.*
Библиографическая ссылка 36. Stillmeadow, Inc. (1980). Ocular irritation study of a mascara product containing 0.4% DMDM Hydantoin. CTFA Code No. 3-5-29.*
Библиографическая ссылка 37. FDRL. (1985). A teratology study with a DMDM Hydantoin formulation in rabbits. Study no. 8259. Submitted to Glyco Chemicals, Inc.*
Библиографическая ссылка 38. Ames, B.N., Mccann, J., and Yamasaki, E. (1975). Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutation Res. 31, 347–64.
Библиографическая ссылка 39. Ames, B.N., Choi, E., Mccann, J., and Yamasaki, E. (1975). Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals. Proc. Natl. Acad. Sci. USA 72, 5135–9.
Библиографическая ссылка 40. Litton Bionetics, Inc. (1978). Mutagenicity evaluation of a DMDM Hydantoin formulation in the Ames Salmonella/microsome plate test. Study No. 20838. Submitted to Glyco Chemicals, Inc.*
Библиографическая ссылка 41. Yahagi, T., Nagao, M., Seino, Y., Matsushima, T., and Sugimura, T. (1977). Mutagenicities of N-nitrosamines on Salmonella. Mutat. Res. 48(2), 121–9.
Библиографическая ссылка 42. Microbiological Associates. (1982). Salmonella/mammalian-microsome mutagenesis assay (Ames test) with a DMDM Hydantoin formulation. Study no. 003-560-723-1.*
Библиографическая ссылка 43. Microbiological Associates. (1982). Salmonella/mammalian-microsome preincubation mutagenicity assay (Ames test) with a DMDM Hydantoin formulation. Study no. T1804.502. Sponsor: Glyco Chemicals, Inc.*
Библиографическая ссылка 44. Clive, D., and Spector, J.F.S. (1975). Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178y mouse lymphoma cells. Mutation Res. 31, 17–29.
Библиографическая ссылка 45. Microbiological Associates. (1982). Test for chemical induction of mutation in mammalian cells in culture. The L5178y Tk+/-mouse lymphoma assay. Study no. 003-561-724-7.*
Библиографическая ссылка 46. Microbiological Associates. (1982). Cytogenicity study-Chinese hamster ovary (CHO) cells in vitro. Study no. T1721.337.*
Библиографическая ссылка 47. Williams, G.M. (1977). Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures. Cancer Res. 37, 1845–51.
Библиографическая ссылка 48. Williams, G.M. (1978). Further improvements in the hepatocyte primary culture DNA repair test for carcinogens: Detection of carcinogenic biphenyl derivatives. Cancer Lett. 4, 69–75.
Библиографическая ссылка 49. CTFA. (1982). Induction of unscheduled DNA synthesis. Study no. YE 504.*
Библиографическая ссылка 50. CTFA. (1983). Induction of unscheduled DNA synthesis. Study no. YE 692.*
Библиографическая ссылка 51. Kohn, K.W., Ewig, R.A.G., Erickson, L.C., and Zwelling, L.A. (1980). Measurement of strand breaks and cross-links by alkaline elution. In: Friedberg, E., and Hanawalt, P. (eds.). Handbook of DNA Repair Techniques. New York: Marcel Dekker, pp. 379–401.
Библиографическая ссылка 52. Bradley, M.O., and Erickson, L.C. (1981). Comparison of the effects of hydrogen peroxide and x-ray irradiation on toxicity, mutation, and DNA damage/repair in mammalian cells (V-79). Biochem. Biophys. Acta 654, 135–41.
Библиографическая ссылка 53. CTFA. (1984). Induction of strand breaks and/or cross-links in testicular DNA. Study no. YE 765.*
Библиографическая ссылка 54. Procter And Gamble Company. (1986). Addendum to industry submission on DMDM Hydantoin in mutagenicity studies.*
Библиографическая ссылка 55. Fregert, E. (1969). Epidemiology of contact dermatitis. Trans. St. Johnʼs Hosp. Derm. Soc. 55, 17.
Библиографическая ссылка 56. CTFA. (1981). Safety Data Test Summary Response form. Skin irritation. CTFA Code no. 3-4-1.*
Библиографическая ссылка 57. Smiles, K.A., and Pollack, M.E. (1977). A quantitative human patch testing procedure for low level skin irritants. J. Soc. Cosmet. Chem. 28, 755–64.
Библиографическая ссылка 58. Finkelstein, P., Laden, K., and Miechowski, W. (1963). New methods for evaluating cosmetic irritancy. J. Invest. Dermatol. 40, 11–4.
Библиографическая ссылка 59. CTFA. (1979). Safety Data Test Summary Response form. Skin irritation. CTFA Code no. 3-4-5.*
Библиографическая ссылка 60. CTFA. (1980). Safety Data Test Summary Response form. Skin irritation. CTFA Code no. 3-4-6.*
Библиографическая ссылка 61. CTFA. (1980). Safety Data Test Summary Response form. Skin irritation. CTFA Code no. 3-4-8.*
Библиографическая ссылка 62. Frosh, P.J., and Kligman, A.M. (1979). The soap chamber test. J. Am. Acad. Dermatol. 1, 35–41.
Библиографическая ссылка 63. CTFA. (1981). Safety Data Test Summary Response form. Skin irritation. CTFA Code no. 3-4-7.*
Библиографическая ссылка 64. CTFA. (1980). Safety Data Test Summary Response form. Skin irritation. CTFA Code no. 3-4-9.*
Библиографическая ссылка 65. HILL Top Research, Inc. (1981). Cumulative skin irritation study of a mascara product containing 0.4% DMDM Hydantoin. CTFA Code No. 3-5-25.*
Библиографическая ссылка 66. HILL Top Research, Inc. (1982). Report of a human skin test of cumulative irritation. Ctfa Code no. 3-4-14.*
Библиографическая ссылка 67. HILL Top Research, Inc. (1982). Report of a human skin test of cumulative irritation. Ctfa Code no. 3-4-15.*
Библиографическая ссылка 68. FDRL. (1981). Clinical safety evaluation of 1% DMDM Hydantoin in water. Study no. 81–035.*
Библиографическая ссылка 69. CTFA. (1980). Safety Data Test Summary Response form. Skin irritation. CTFA Code no. 3-4-11.*
Библиографическая ссылка 70. CTFA. (1980). Safety Data Test Summary Response form. Skin irritation. CTFA Code no. 3-4-10.*
Библиографическая ссылка 71. IVY Research Laboratories, Inc. (1982). The determination of the contact-sensitizing potential of four materials by means of the maximization study. CTFA Code no. 3-4-16.*
Библиографическая ссылка 72. Kligman, A.M., and Epstein, W. (1975). Updating the maximization test for identifying contact allergens. Contact Derm. 1, 231–9.
Библиографическая ссылка 73. Derma-Test Laboratories, Inc. (1981). Maximization potential evaluation of a mascara product containing 0.4% DMDM Hydantoin. CTFA Code No. 3-5-24.*
Библиографическая ссылка 74. Bio-Test Laboratories, Inc. (1977). Human photosensitization study with a DMDM Hydantoin formulation. Study no. 8537–09669. Submitted to Glyco Chemicals, Inc.*
Библиографическая ссылка 75. FDRL. (1981). Clinical safety evaluation of a DMDM Hydantoin formulation. CTFA Code no. 3-4-17.*
Библиографическая ссылка 76. FDRL. (1981). Clinical safety evaluation of a DMDM Hydantoin formulation. CTFA Code no. 3-4-18.*
Библиографическая ссылка 77. Lanman, B.M. (1968). Joint Conference on Cosmetic Sciences, April 21–23. Washington, DC. (Modified by PHILLIPS et al [1972] Toxicology and Applied Pharmacology 21, 369–82.)
Библиографическая ссылка 78. Phillips, L., Steinberg, M., Maibach, H., and Akers, W. (1972). Toxicol. Appl. Pharmacol. 21, 369–82.
Библиографическая ссылка 79. Hill Top Research, Inc. (1982). Repeated insult patch test with a DMDM Hydantoin formulation. Study no. 82-0078-72(B).*
Библиографическая ссылка 80. Curwen, W.L., and Jillson, E.F. (1960). Light hypersensitivity. J. Invest. Dermatol. 34, 207–12.

Скрыть метаданые